Precision Medicine: medical care designed to optimize efficiency or therapeutic benefit for particular groups of patients, especially by using genetic or molecular profiling.
-
This webinar offers a unique opportunity to hear directly from Professor Mathias Uhlén, lead author of the recent Science publication introducing the human pan-disease blood atlas. Bu...
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
Discover how intelligent assistants at Merck are transforming the way scientific teams engage with complex datasets. This webinar will demonstrate how researchers can intuitively explore and...
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
JUL 31, 2025 | 8:00 AM
C.E. CREDITS
Explore the insights shared at ASHG 2024 on MVP-ROAR and AutoMitoC—now available on-demand. This Educational Session underscores the value of healthcare-linked biobanks and computation...
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
Join us for a live webinar on the latest advancements in spatial biology. Featuring two insightful presentations, learn how cutting-edge imaging and single-cell technologies are transforming...
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting the joints, entheses, and skin, while also increasing the risk of cardiovascular disease (CVD) and metabolic dysfunction...
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD)...
NOV 14, 2024 | 12:00 PM
C.E. CREDITS
Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often mask...
Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer...
SEPT 23, 2024 3:00 PM CET
CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before...
In the rapidly evolving field of oncology, precision medicine stands at the forefront of providing personalized patient care. Our upcoming webinar, "Transforming Oncology Diagnostics: I...
The Molecular Twin is a proof-of-principle platform that combines data from several clinical and molecular analytes from both tumor and host and applies AI and machine learning approaches to...
Over 95% of potential anti-cancer drugs failed in clinical trials despite vast investment to bring the drug to market. The last decade of cancer research has also seen numerous advances aime...
Measurable or minimal residual disease (MRD) is the presence of very small numbers of tumor cells which may remain in the body following treatment. MRD testing currently has multiple clinica...
Prof Pantel will give an introduction and review to the evolution of precision medicine and will then focus on the implementation of Liquid Biopsy in Precision Oncology....
With the increasing number, complexity, and diversity of biomarkers to be tested in support of precision medicine approaches, limited tissue availability and patient health status can be bar...